192 related articles for article (PubMed ID: 9071946)
1. Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution?
Sahmoud T; Mary JY; Sahmoud T
Gut; 1997 Feb; 40(2):284-5. PubMed ID: 9071946
[No Abstract] [Full Text] [Related]
2. Drug choice in preventing postoperative Crohn's disease.
Korelitz BI
Gastroenterology; 1996 Feb; 110(2):652-3. PubMed ID: 8566620
[No Abstract] [Full Text] [Related]
3. The role of mesalazine in Crohn's disease.
Hanauer SB
Scand J Gastroenterol Suppl; 1990; 172():56-9. PubMed ID: 1972296
[TBL] [Abstract][Full Text] [Related]
4. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease.
Bonapace CR; Mays DA
Ann Pharmacother; 1997; 31(7-8):907-13. PubMed ID: 9220055
[TBL] [Abstract][Full Text] [Related]
5. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.
Sutherland LR; Martin F; Bailey RJ; Fedorak RN; Poleski M; Dallaire C; Rossman R; Saibil F; Lariviere L
Gastroenterology; 1997 Apr; 112(4):1069-77. PubMed ID: 9097988
[TBL] [Abstract][Full Text] [Related]
6. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.
Steinhart AH; Hemphill D; Greenberg GR
Am J Gastroenterol; 1994 Dec; 89(12):2116-24. PubMed ID: 7977225
[TBL] [Abstract][Full Text] [Related]
7. Mesalazine as maintenance treatment in Crohn's disease.
Vos J; Lesterhuis W
Gastroenterology; 1994 Feb; 106(2):553-4. PubMed ID: 8299923
[No Abstract] [Full Text] [Related]
8. A controlled double blind multicenter study of the effectiveness of 5-aminosalicylic acid in patients with Crohn's disease in remission.
Arber N; Odes HS; Fireman Z; Lavie A; Broide E; Bujanover Y; Becker S; Pomerantz I; Moshkowitz M; Patz J
J Clin Gastroenterol; 1995 Apr; 20(3):203-6. PubMed ID: 7797827
[TBL] [Abstract][Full Text] [Related]
9. Drug insight: aminosalicylates for the treatment of IBD.
Nielsen OH; Munck LK
Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
[TBL] [Abstract][Full Text] [Related]
10. [Pentasa (mesalazine) and pregnancy].
Jonville-Bera AP; Soyez C; Fignon A; Moraine C; Berger C; Autret E
Therapie; 1994; 49(5):443-5. PubMed ID: 7855761
[TBL] [Abstract][Full Text] [Related]
11. [Mesalazine].
Engelhardt K; Mohr K
Dtsch Med Wochenschr; 1995 May; 120(21):769-70. PubMed ID: 7781502
[No Abstract] [Full Text] [Related]
12. Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
Modigliani R; Colombel JF; Dupas JL; Dapoigny M; Costil V; Veyrac M; Duclos B; Soulé JC; Gendre JP; Galmiche JP; Danne O; Cadiot G; Lamouliatte H; Belaïche J; Mary JY
Gastroenterology; 1996 Mar; 110(3):688-93. PubMed ID: 8608877
[TBL] [Abstract][Full Text] [Related]
13. [Diffuse alopecia as side effect of mesalazine therapy in Crohn's disease].
Netzer P
Schweiz Med Wochenschr; 1995 Dec; 125(50):2438-42. PubMed ID: 8553032
[TBL] [Abstract][Full Text] [Related]
14. Mesalazine as a maintenance treatment in Crohn's disease.
Sutherland LR; Steinhart AH
Gut; 1998 Jan; 42(1):143-4. PubMed ID: 9505902
[No Abstract] [Full Text] [Related]
15. [Postoperative recurrence in Crohn's disease].
Caprilli R; Taddei G; Viscido A
Chir Ital; 1995; 47(5):25-32. PubMed ID: 9162601
[TBL] [Abstract][Full Text] [Related]
16. Postoperative recurrence of Crohn's disease: pathogenesis and prevention.
D'Haens GR; Rutgeerts PJ
Acta Gastroenterol Belg; 1994; 57(5-6):311-3. PubMed ID: 7709700
[TBL] [Abstract][Full Text] [Related]
17. [Salicylates in the treatment of Crohn disease].
Mangiarotti R; Prantera C
Ann Ital Chir; 1994; 65(3):279-81. PubMed ID: 7887577
[No Abstract] [Full Text] [Related]
18. Leukocyte-endothelial cell interactions: potential targets for mesalazine in Crohn's disease.
Wakefield AJ; Hudson M; Pounder RE
Adv Exp Med Biol; 1995; 371B():1307-11. PubMed ID: 7502806
[No Abstract] [Full Text] [Related]
19. 5-Aminosalicylic acid-associated renal tubular acidosis with decreased renal function in Crohn's disease.
Hämling J; Raedler A; Helmchen U; Schreiber S
Digestion; 1997; 58(3):304-7. PubMed ID: 9243128
[TBL] [Abstract][Full Text] [Related]
20. Is it possible to prevent recurrent Crohn's disease with medical or surgical interventions?
Mcleod RS
Neth J Med; 1996 Feb; 48(2):68-70. PubMed ID: 8819803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]